Matrix Laboratories Ltd has informed BSE that Mr Rajiv Malik, the incumbent Managing Director and Chief Executive Officer of the Company will be relocated to US in connection with his employment by the parent company, Mylan Inc. He will be succeeded by Mr Jagadish Dore. The effective dates for relocation / date of joining will be finalised subsequently.

In this regard the Company has issued the following Press Release:

The Company on February 27, 2008 has announced the appointment of Jagdish Viswanath Dore as CEO. Mr. Dore will assume the responsibilities of Rajiv Malik who became Executive Vice President and Head of Global Technical Operations for Mylan Inc. in October 2007 and has been serving as interim CEO for the Company, a majority-owned subsidiary of Mylan. Mr. Malik will be relocated to the U.S in connection with his employment by Mylan.

The Company’s Chairman, Robert J Coury said: “Jagdish?s impressive industry reputation is well known, and I believe he will be a huge asset to Matrix as it continues to expand its integral role in support of Mylan?s global platform. I have every confidence that Jagdish will ensure that Matrix continues its strong growth and supports Mylan in becoming the world?s leading, fully-integrated generic pharmaceuticals company.”

Mr. Dore said: “Matrix is an established, highly respected and high-quality company in the pharmaceuticals industry both in India and world-wide. It is only enhanced by being part of Mylan. I look forward to leading Matrix into the next phase of its growth and working with the Mylan and Matrix senior management teams to further align our organizations and leverage the opportunities available to us in the global generics market.”